BioMarin vs Travere Therapeutics
BioMarin vs Travere Therapeutics, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BioMarin is on 36/100 and Travere Therapeutics on 51/100.
Where each one leads
BioMarin
- domain rating: 72/100 against 58/100
- headcount: 3,163 against 125
Travere Therapeutics
- our overall score: 51/100 against 36/100
At a glance
| Measure | BioMarin | Travere Therapeutics |
|---|---|---|
| What it is | A global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. | A biopharmaceutical company focused on developing and commercializing therapies for rare diseases. |
| Category | Biotechnology, Rare Diseases, Genetic Disorders, Enzyme Replacement Therapies | Biotechnology, Pharmaceuticals, Healthcare, Rare Diseases |
| Sells toBusiness model | B2B | B2B |
| Offering | Biotechnology | Services |
| Founded | 1997 | 2015 |
| Headquarters | San Rafael, United States | San Diego, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | BioMarin | Travere Therapeutics |
|---|---|---|
| Employees | 3,163 | 125 |
| Total funding | Not published | $63.0M |
| Latest round | Not published | Convertible Note |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 225,828 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BioMarin | Travere Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 36/100 | 51/100 |
| Traction | 20/100 | 59/100 |
| Team | 70/100 | 50/100 |
| Search visibility | 23/100 | 5/100 |
| Quality | Not published | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 72/100 | 58/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BioMarin | Travere Therapeutics |
|---|---|---|
| Hosting | Azure | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery, Tailwind CSS |
| Analytics | Google Tag Manager | Google Tag Manager, Linkedin Insight |
BioMarin vs Travere Therapeutics: common questions
Which is better, BioMarin or Travere Therapeutics?
On our 0-100 score Travere Therapeutics rates higher (51/100 against 36/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do BioMarin and Travere Therapeutics compare on the numbers?
BioMarin leads on domain rating (72/100 against 58/100), headcount (3,163 against 125). Travere Therapeutics leads on our overall score (51/100 against 36/100).
Read the full BioMarin review and pricing or the Travere Therapeutics review and pricing. You can also browse other BioMarin alternatives we track.